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Abstract 29 
Campylobacter has been the most commonly reported cause of bacterial diarrhoeal 30 
disease in humans in the EU since 2005 (EFSA, 2016). Most broiler batches at slaughter 31 
are colonized with Campylobacter and the major source of infection is contaminated 32 
poultry meat. The aim of this study was to characterize a selection of C. jejuni and C. 33 
coli isolates from broilers through whole genome sequencing (WGS). A total of 16 34 
isolates (C. jejuni = 12 and C. coli = 4) from five broiler farms from Catalonia 35 
(northeastern Spain) were analyzed. A phylogenetic analysis based on 8420 SNPs 36 
showed two main clusters grouping strains by species. Phenotypic resistances to 37 
quinolones (100%), tetracycline (81%), streptomycin (75%), erythromycin (56%) and 38 
gentamicin (13%) were found. All the isolates carried the C257T point mutation in the 39 
subunit A of the DNA gyrase gene (Thr86Ile) conferring resistance to quinolones, 40 
whilst all the isolates showing resistance to tetracycline carried the tet(O) gene. The 41 
genes aph(3´)-III and aadE conferring resistance to aminoglycosides were identified in 42 
the two isolates (one C. jejuni and one C. coli) resistant to streptomycin and gentamicin. 43 
The point mutation A2075G on the 23S rDNA conferring high resistance to macrolides 44 
was detected in three C. coli isolates. The CmeABC multidrug efflux pump was also 45 
detected, both in C. jejuni and C.coli isolates. All C. jejuni and C. coli isolates were 46 
positive for most of the 34 virulence-associated genes studied related to motility, 47 
chemotaxis, adhesion and invasion. Interestingly, the wlaN gene involved in the 48 
Guillain-Barré syndrome, was found in two isolates. The results underline the power of 49 
WGS for investigation of virulence, clonality and antimicrobial resistance in 50 
Campylobacter.  51 
 52 
53 
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 Introduction 54 
Since 2005 Campylobacter has outnumbered Salmonella as the most commonly 55 
reported cause of bacterial diarrhoeal disease in humans in the EU (EFSA 2014). C. 56 
jejuni and C. coli are responsible for the vast majority of infections (Eberle & Kiess 57 
2012), which may subsequently lead to serious neuropathy such as Guillain-Barré 58 
syndrome (Crushell et al. 2004). The majority of Campylobacter infections in humans 59 
are sporadic and self-limiting which complicates the determination of the true incidence 60 
rate (Hänninen et al. 2000). Due to the self-limiting behavior of the disease 61 
antimicrobial treatment is only indicated in severe cases where fluoroquinolones and 62 
macrolides are the drugs of choice (Butzler 2004; Moore et al. 2006). 63 
 64 
In the majority of the EU countries most of the broiler batches are colonized with 65 
Campylobacter at slaughter and the main source of campylobacteriosis in humans is 66 
chicken meat, which can account for up to 70% of cases (Boysen et al. 2014). The 67 
prevention of broiler flock colonization has therefore become a food safety priority in 68 
the EU (EFSA, 2011), that is reflected by the new regulation (amendment of Annex I to 69 
EC regulation No 2073/2005 as regards Campylobacter in broiler carcasses) that may 70 
enter into force  in 2018.  71 
  72 
The pathogenicity of Campylobacter strains have been linked to multiple factors 73 
including host susceptibility and, more importantly, the expression of different 74 
virulence factors and resistance to antimicrobials. Several putative virulence factors 75 
have been identified in Campylobacter species that contribute to motility, intestinal 76 
adhesion, colonization, toxin production and tissue invasion (Dasti et al. 2010; Bolton 77 
2015). Also, multidrug-resistant C. jejuni and C. coli have been reported worldwide 78 
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from farm animals and retail meats, including poultry and swine (Zhao et al. 2010; 79 
Datta et al. 2003). 80 
 81 
Phenotypic methods have been widely used to characterize C. jejuni and C. coli strains. 82 
However, these methods have mostly been replaced by genotypic methods that are more 83 
accurate and have higher discrimination power, such as pulsed-field gel electrophoresis 84 
(PFGE) and multilocus sequence typing (MLST) (Pfaller 1999). Nevertheless, with the 85 
advent of next-generation sequencing, the possibility of generating high-resolution full 86 
genome data is being increasingly used to differentially characterize strains. This 87 
technology allows for a rapid identification of a broad range of genotypic traits of the 88 
isolates, such as their pool of virulence and antimicrobial resistance determinants. It has 89 
proven useful in gaining insight into the epidemiology of Campylobacter and predicting 90 
its antimicrobial resistance (Llarena et al 2017; Zhao et al 2015). Hence, the aim of this 91 
study was to take advantage of whole genome sequencing (WGS) to in-depth 92 
characterize a subset of C. jejuni and C. coli isolates from broilers obtained from a 93 
longitudinal study involving different farms. The characterization included the 94 
determination of the MLST genotype, the identification of virulence and antimicrobial 95 
determinants as well as a phylogenetic study of the isolates through the discovery of 96 
single nucleotide polymorphisms (SNPs) between the different strains analyzed. 97 
 98 
Materials and Methods 99 
Isolates 100 
A total of 16 poultry isolates (C. jejuni =12 and C. coli= 4) from five broiler farms 101 
were included in the study. The isolates were selected from Campylobacter positive 102 
flocks of a broad two-year longitudinal study (2011-2013), where six to seven flocks 103 
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were studied each year by cloacal swab sampling a subset of birds. Selection of the 104 
isolates was performed according to their PFGE patterns (Supplementary Fig. 1) and an 105 
antimicrobial multidrug-resistant profile by disc diffusion (unpublished data). The five 106 
different farms (A, B, C, D and E) were located in Catalonia (northeastern Spain). 107 
Poultry houses had a capacity of 12,000 to 46,000 birds, and age of sampled birds 108 
ranged 18 to 39 days. Campylobacter isolation and identification was performed as 109 
previously described (Urdaneta et al., 2015). Isolates were preserved in brain heart 110 
infusion broth (BHI, Merck KGaA, Darmstadt, Germany), with 20% glycerol at -80ºC 111 
until used and fresh cultures of the isolates were prepared on Columbia blood agar 112 
plates (bioMérieux, Marcy-l’Etoile, France). Plates were incubated at 37 °C for 48 h 113 
under microaerobic conditions using a microaerobic atmosphere generator (Anaerocult® 114 
C, Merck, Darmstadt, Germany).  115 
 116 
Antimicrobial susceptibility testing 117 
Isolates were tested for antimicrobial susceptibility using a minimum inhibitory 118 
concentration (MIC) based broth microdilution (VetMIC GN-mo; National Veterinary 119 
Institute, Uppsala, Sweden) for the following antimicrobial agents: nalidixic acid (1 to 120 
64 mg/L), ciprofloxacin (0.06 to 8 mg/L), tetracycline (0.12 to 16 mg/L), streptomycin 121 
(0.5 to 64 mg/L), gentamicin (0.12 to 16 mg/L), and erythromycin (0.5 to 64 mg/L). C. 122 
jejuni ATCC 33560 and C. coli ATCC 33559 were used as control strains. An isolate 123 
was considered multidrug-resistant when showing resistance to three or more non-124 
related antimicrobials. Isolates were considered to be susceptible or resistant based on 125 
epidemiological cutoff values according to EUCAST guidelines (www.eucast.org). 126 
When reporting data using EUCAST epidemiological cut-off values, bacteria should be 127 
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reported as ‘wild-type’ (WT) or ‘non-wild-type’ (non-WT) (Schwarz et al. 2010). For 128 
simplicity of the terms, susceptible and resistant has been used here. 129 
 130 
Whole genome sequencing (WGS) and assembly 131 
Genomic DNA was extracted using QIAamp DNA mini kit (QIAGEN) according to the 132 
manufacturer´s instructions. The libraries were prepared with Nextera XT DNA sample 133 
preparation kit (Illumina Inc., San Diego, CA, cat. no. FC-131-1024) followed by 134 
multiplexed paired-end sequencing with a read length of 2 × 251 bp, using Illumina’s 135 
MiSeq platform (Illumina). 136 
 137 
The raw reads were trimmed and cleaned for adapters, and assembling was performed 138 
using the online tool Assembler v1.2 with default parameters. All these steps are 139 
integrated in a pipeline available at the Center for Genomic Epidemiology (CGE) 140 
(www.genomicepidemiology.org). Contiguous assemblies were analyzed using the 141 
CLCbio’s Genomics Workbench v6.5 (CLCbio’s, Aarhus, Denmark).  142 
 143 
The raw sequence dataset is available in the NCBI database with Bioproject Accession 144 
number PRJNA385807. 145 
 146 
Analysis of resistance and virulence-associated genes 147 
ResFinder v2.1 (https://cge.cbs.dtu.dk/services/ResFinder/) and MyDbFinder v1.1 148 
(https://cge.cbs.dtu.dk/services/MyDbFinder/), both available at the CGE were used for 149 
identification of resistance and virulence genes, respectively. All strains were subjected 150 
to analysis of the presence of resistance determinants to quinolones, tetracyclines, 151 
aminoglycosides and β-lactams. C. jejuni and C. coli strains were tested for 34 152 
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virulence-associated genes; the identifiers of each of the genes analyzed and the 153 
homology analyses are detailed in Supplementary Tables 2 and 3, respectively. The 154 
presence of several virulence-associated genes related to motility (eight), chemotaxis 155 
(five), adhesion (four), invasion (three), cytolethal distending toxin (three), multidrug 156 
and bile resistance (three), stress response and survival (two), iron uptake (two), capsule 157 
(two), Guillian-Barré syndrome (one) and hippuricase (one), was assessed (Koolman et 158 
al. 2015). All genes were identified with a selected identity threshold of 80% (Zankari 159 
et al. 2012), and a minimum coverage of 20% of the query sequence length. The 160 
presence of the flaA and flaB motility genes was confirmed by PCR with specific 161 
primers (Koolman et al. 2015). 162 
 163 
In order to analyze the presence/absence of specific mutations related to antibiotic 164 
resistance, the raw fastq files for each of the isolates were aligned with bwa mem 165 
algorithm (Li & Durbin 2009) with the corresponding reference genome (AL111168 for 166 
C. jejuni and CP011015 for C. coli). The alignment files and the corresponding 167 
annotated reference genome were inspected manually using Tablet as the visualizing 168 
tool (Milne et al. 2013). Only mutations that appeared with frequency higher than 0.5% 169 
were considered.   170 
 171 
Identification of SNPs 172 
The SNP discovery was done using the CSI Phylogeny v1.4 pipeline CGE (Kaas et al. 173 
2014). Briefly, the paired-end reads from each of the isolates were reference-aligned 174 
using strain 12 for C. jejuni and 4 for C. coli with BWA v.0.7.2 software (Li & Durbin 175 
2009). SNP calling was done with SAMtools v.0.1.18 (‘mpileup’ method, Li & Durbin 176 
2009) and filtering was done with BEDTools (Quinlan & Hall 2010). To select the valid 177 
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SNPs, the same criteria previously described was followed (Kaas et al. 2014). SNPs 178 
were filtered out if the mapping quality was below 25 or the SNP quality was below 30, 179 
and if they were called within the vicinity of 10 bp of another SNP (pruning). To 180 
perform the phylogenetic analysis, concatenation of the sequences and subsequent 181 
aligning with MUSCLE was done (Edgar 2004). Maximum likelihood trees were 182 
created using CSI Phylogeny 1.4 (available at 183 
https://cge.cbs.dtu.dk/services/CSIPhylogeny/) (Price et al. 2010) using the following 184 
parameters: minimum depth at SNP position was set at 10x, the minimum SNP quality 185 
accepted was 30 and the minimum read mapping quality allowed was 25. The reference 186 
genome used was C. coli (Accession number CP011015). 187 
 188 
Multilocus sequence typing (MLST) 189 
The de novo assembled contigs were used to identify the multilocus sequence types 190 
(ST) and clonal complexes (CC) using the web server MLST v1.8 available at the CGE 191 
website (www.genomicepidemiology.org). 192 
 193 
Results 194 
Whole genome sequencing 195 
The isolates were sequenced to an average coverage that varied from 49,73 to 127,2 x 196 
(Supplementary Table 1). From the assembled contigs of the sixteen isolates, nine 197 
previously-described sequence types (ST) were recognized (Fig. 1). Besides, two novel 198 
STs not previously reported in the PubMLST database 199 
(http://pubmlst.org/campylobacter/) were identified, ST8586 (E13, C. jejuni isolate) and 200 
ST8578 (E16, C. coli isolate). All the STs found belong to five different CC. The most 201 
frequent CC in C. jejuni were CC257 and CC21 followed by CC206, whilst the less 202 
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prevalent was CC45 with only one C. jejuni isolate from ST45 belonging to this group. 203 
All of the C. coli isolates belonged to the same clonal complex (CC828), which 204 
included three different STs (ST827, ST854 and ST8578).  205 
 206 
Comparison of the sequences obtained from the sixteen isolates allowed the 207 
identification of a total of 8420 SNPs, which were used to perform the phylogenetic 208 
analysis. The representation of the SNP tree is depicted in Fig. 1 and a heatmap 209 
representing the SNP counts between the genomes is shown in Supplemental Fig. 2.  210 
None of the isolates analyzed were identical. The isolates showed distribution in two 211 
main clusters, with all strains grouped by species.  212 
 213 
Antimicrobial susceptibility 214 
The phenotypic antimicrobial susceptibility patterns determined for the sixteen strains 215 
analysed is shown in Table 1. All the strains showed a multidrug resistant profile, with 216 
resistance to quinolones (nalidixic acid and ciprofloxacin) being common to all of them. 217 
The resistance to tetracycline was the second most commonly observed (81%) followed 218 
by streptomycin and erythromycin resistance (75% and 56%, respectively). Among the 219 
latter, one third of C. jejuni isolates were resistant, whilst all C. coli isolates showed 220 
resistance to this antimicrobial. Gentamicin resistance was the less prevalent, detected 221 
only in two isolates from farms A and B (13%).  222 
 223 
In order to study the potential mechanisms of antimicrobial resistance, the assembled 224 
genomes of each of the strains under study were investigated for particular patterns 225 
known to be associated to resistance. Phenotypic antimicrobial resistances obtained with 226 
the MIC analysis corresponded well for most of the isolates with the identification of 227 
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specific antimicrobial resistance genes detected by WGS (Table 1). All the isolates 228 
carried the C257T point mutation in the subunit A of the DNA gyrase gene (Thr86Ile) 229 
conferring resistance to quinolones. Other less common mutations in gyrA (Asp-90-Asn 230 
and Ala-70-Thr) were not detected in any of the isolates. All the isolates showing 231 
resistance to tetracycline carried the tet(O) gene. Within the two isolates resistant to 232 
streptomycin and gentamicin, the genes aph(3´)-III and aadE conferring resistance to 233 
aminoglycosides were identified. Three C. coli isolates were found to show a mutation 234 
in the A2075G position of the 23S rDNA region, which confers a high level of 235 
resistance to macrolides. The CmeABC multidrug efflux pump has been described as 236 
the major efflux pump mechanism conferring resistance to a wide range of 237 
antimicrobials, and it was identified in 15 out of the 16 isolates analyzed.  238 
 239 
Virulence determinants 240 
All isolates of C. jejuni and C. coli were positive for almost all of the 34 virulence-241 
associated genes studied, including motility, chemotaxis, adhesion and invasion genes, 242 
with few exceptions (Table 2). The flagellin genes were unexpectedly found absent in 243 
most of the strains through WGS analysis. However, due to the known difficulty 244 
associated to accurately assemble duplicated genes, the presence of these flaA and flaB 245 
genes was assessed by PCR. Table 2 shows the experimentally-validated presence of 246 
flaB in all the isolates and absence of flaA in one third of the isolates by specific PCR. 247 
Only one isolate was negative for cmeB (component of the CmeABC efflux pump) and 248 
another one for cfrA (gene involved in iron uptake), both were C. jejuni strains from 249 
farm E. Remarkably, the wlaN gene, involved in the Guillain-Barré syndrome, was 250 
detected in two C. jejuni isolates from different farms. As expected, the hipO gene was 251 
not detected in any C. coli isolate. 252 
253 
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 254 
Discussion  255 
The whole-genome sequence data revealed that the C. jejuni and C. coli isolates 256 
belonged to five different CC, all of them associated both with poultry and human 257 
campylobacteriosis in many countries (Campylobacter PubMLST; 258 
http://PubMLST.org). The two positive isolates to wlaN gene, related to the Guillain 259 
Barré Syndrome, belonged to ST21 and to the novel ST8586, both from CC21. In the 260 
Campylobacter PubMLST database, there are only seven isolates within CC21 261 
associated with the Guillain-Barré syndrome and none of them belong to the widespread 262 
ST21. 263 
 264 
The comparison of the assembled genomes revealed a large number of nucleotide 265 
changes (SNPs), among the isolates and the reference genomes. The identified 266 
variations were used to study the phylogeny to infer the relationship among the isolates, 267 
which were in concordance to the species they belong (Fig. 1). Not surprisingly, isolates 268 
of identical ST were more closely related compared to isolates of different STs. 269 
 270 
The antimicrobial resistance found are of relevance in a public health context, 271 
particularly those to fluoroquinolones and macrolides (mainly ciprofloxacin and 272 
erythromycin, respectively), but also tetracyclines and aminoglycosides. Quinolones 273 
and macrolides are the antibiotic of choice to treat severe human Campylobacter 274 
infections, whilst tetracyclines are used as an alternative treatment (Moore et al. 2006; 275 
Butzler 2004) and aminoglycosides are recommended to treat bacteraemia caused by 276 
Campylobacter (Kassa et al. 2007). Resistance to fluoroquinolones and macrolides is 277 
quite common in poultry (Thakur 2010). High quinolone resistance in poultry has 278 
previously been reported in Spain (Pérez-Boto et al. 2013; Melero et al. 2012), as well 279 
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as in other EU countries (Luber et al. 2003; Nobile et al. 2013).  The high MIC values 280 
detected here may be related to the presence of Thr86Ile in all of the isolates, which in 281 
itself provides high resistance to quinolones (MIC >16 mg/L) (Ruiz et al. 1998). This 282 
mutation is the most prevalent in clinical and veterinary isolates (Hormeño et al. 2016; 283 
Butzler 2004). The high prevalence of isolates resistant to tetracyclines is similar to that 284 
previously reported in poultry in Spain (Pérez-Boto et al. 2013; Melero et al. 2012; 285 
Duarte et al. 2016). This resistance is mediated by the tet(O) gene which was detected in 286 
all isolates showing tetracycline resistance. Besides the chromosomal location of this 287 
gene, it has also been reported in plasmids (Avrain et al. 2004; Iovine 2013). In contrast, 288 
resistance to aminoglycosides was diverse, with a considerably high resistance to 289 
streptomycin (75%) and a much lower resistance to gentamicin (13%), in agreement 290 
with Duarte et al. (2016) and Pérez-Boto et al. (2013). Gentamicin resistance in 291 
Campylobacter spp. from poultry is a rare event all over European countries (Carreira et 292 
al. 2012; De Jong et al. 2009; Pérez-Boto et al. 2013), probably because it is not used in 293 
poultry production. The aph(3´)-III and aadE genes involved in aminoglycoside 294 
resistance were identified in some strains. However, the finding of a high resistance to 295 
streptomycin in some of the strains despite the absence of corresponding genes might be 296 
due to the presence of undiscovered genes. Nevertheless, the present work was focused 297 
on chromosomal genes, so whether these strains carried plasmids encoding 298 
streptomycin resistance-genes cannot be ruled out and deserve further research (Iovine 299 
2013). Over 50% of isolates were resistant to erythromycin and was more common 300 
among C. coli than C. jejuni, similarly to what has been previously reported in poultry 301 
in the EU (Duarte et al. 2016; Wimalarathna et al. 2013). Erythromycin resistance is 302 
acquired through point mutations in domain V of the 23S rDNA at positions 2074 and 303 
2075 (positions 2058 and 2059 in E. coli numbering) (Iovine 2013); the point mutation 304 
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A2075G which is the most prevalent in Campylobacter spp. and confers high-level 305 
resistance to macrolides, was identified in three C. coli isolates. The overall resistances 306 
detected here are those also common in food-producing animals in the EU, as reported 307 
by EFSA (2015). Particularly, the pattern of resistance among Campylobacter isolates 308 
was predominantly quinolones (ciprofloxacin and nalidixic acid) and tetracyclines, 309 
whilst resistance to erythromycin and gentamicin was comparatively low. This is most 310 
probably due to the frequent use of enrofloxacin (quinolone) and doxycycline 311 
(tetracycline) in the studied farms. 312 
 313 
Several virulence factors have been identified in Campylobacter, which include 314 
flagella-mediated motility, bacterial adherence to intestinal mucosa, invasive capability 315 
and the ability to produce toxins. C. jejuni isolates were positive for the presence of 316 
most of the virulence genes analyzed related to these virulence factors. However, few 317 
strains were negative for the flaA gene, whilst all were positive for the flaB gene. Those 318 
adjacent genes encode for the protein flagellin which compose the flagellar filament, an 319 
important colonization factor (Silva et al. 2011; Koolman et al. 2015). Isolates negative 320 
for the flaA gene might have reduced motility and colonization ability (Neal-McKinney 321 
et al. 2010). The gene wlaN, responsible for the expression of Guillain-Barré syndrome, 322 
was detected with a low frequency, in agreement with other reports (Koolman et al. 323 
2015; Datta et al. 2003; Talukder et al. 2008). In contrast, the multidrug CmeABC 324 
efflux system, which has a role in antimicrobial resistance, was present in all but one 325 
isolate that lacked the CmeB gene. The efflux system is common in Campylobacter and 326 
consists of an external membrane protein (CmeC), a drug transporter in the internal 327 
membrane (CmeB) and an external membrane protein (CmeA). They all form a 328 
membrane channel that expels toxic substances from the cell (Lin et al. 2002). The hipO 329 
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gene, which is specific for C. jejuni, was not present in any of the C. coli isolates. 330 
Besides this gene, and the wlaN gene, which is relatively rare, all virulence genes 331 
analyzed were present in all C. coli strains. It is noteworthy to highlight that the sodB 332 
gene involved in stress defense, and that was recently first reported in C. coli isolates by 333 
Koolman et al. (2015), has also been found in all C. coli isolates in this study. 334 
 335 
Altogether, the in-depth characterization of these poultry isolates contributes to the 336 
understanding of Campylobacter epidemiology. WGS technology has become a fast and 337 
affordable tool and may become a rapid and cost-effective approach to characterize 338 
isolates from epidemiological studies (Llarena et al. 2017).  339 
340 
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1 
 
Figure legends 1 
 2 
Figure 1. Maximun-likelihood phylogenetic tree based on SNPs from the assembled 3 
genomes and genotypic MLST types of the Campylobacter isolates. The tree was drawn 4 
to scale, with branch lengths measured in the number of substitutions per site. 5 
a Reference genomes for C. jejuni NCTC 11168 (Accession number: AL111168) and for 6 
C. coli FB1 (Accession number: CP011015) were included in the analysis. The tree was 7 
drawn to scale, with branch lengths measured in the number of substitutions per site. 8 
b ST, sequence type; CC, clonal complex. 9 
 10 
Supplementary Fig. 1. PFGE combined dendrogram of SmaI and KpnI patterns of C. 11 
jejuni and C. coli isolates. 12 
 13 
Supplementary Fig. 2. Heatmap representing the SNPs between the genomes. 14 
 15 
 a Nal: Nalidixic acid, Ci: Ciprofloxacin, Tc: Tetracycline, Sm: Streptomycin, Gm: Gentamicin and Ery: Erythromycin.  
b Interpretation of MIC values for C. jejuni epidemiological cut-off values: Nal (R  ≥ 16 mg/L); Ci (R  ≥  0,5 mg/L); Tc (R  ≥  1 mg/L); Sm (R  ≥ 4 mg/L);  Gm 
(R  ≥ 2 mg/L) and Ery (R  ≥   4 mg/L). Interpretation for C. coli epidemiological cut-off values: Nal (R  ≥ 16 mg/L); Ci (R  ≥ 0,5 mg/L); Tc (R  ≥   2 mg/L); 
Sm (R  ≥  4 mg/L);  Gm (R  ≥   2 mg/L) and Ery (R  ≥   8 mg/L). 
c R-mech: resistance mechanism. Thr86Ile: point mutations in the subunit A of the DNA gyrase gene; tet(O), aphA(3’) and aadE: presence of these 
genes; 23S rDNA: point mutation on this region of the genome. 
Nal 
a Ci R-mech 
c 
Thr86Ile
Tc
R-mech 
tet(O)
Sm
R-mech 
aphA(3´)
R-mech 
aadE
Gm  
R-mech 
aphA(3´)
Ery
R-mech 
23S rDNA
A1 C. coli R (> 64) b R (> 8) + S (0,5)  R (32) +  R (2) + R (32) + + + + 
A2 C. jejuni R (32) R (> 8) + S (0,5)  S (0,5)   S (0,12)  R (32)  + + + 
B3 C. jejuni R (> 64) R (> 8) + R (> 16) + R (32)   S (0,12)  R (> 64)  + + + 
B4 C. jejuni R (32) R (0,5) + R (> 16) + R (8)   S (0,12)  S (1)  + + + 
B5 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64) + + R (2) + S (0,5)  + + + 
B6 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64)   S (1)  S (1)  + + + 
C7 C. coli R (> 64) R (4) + R (2) + R (32)   S (0,12)  R (> 64) + + + + 
C8 C. coli R (> 64) R (4) + R (> 16) + R (> 64)   S (0,25)  R (> 64) + + + + 
C9 C. jejuni R (32) R (4) + R (> 16) + S (0,5)   S (0,12)  S (1)  + + + 
C10 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64)   S (0,12)  R (> 64)  + + + 
D11 C. jejuni R (> 64) R (> 8) + R (> 16) + S (0,5)   S (0,12)  S (1)  + + + 
D12 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64)   S (1)  R (> 64)  + + + 
E13 C. jejuni R (> 64) R (4) + R (> 16) + S (0,5)   S (0,12)  S (1)  + + + 
E14 C. jejuni R (> 64) R (> 8) + R (> 16) + R (> 64)   S (0,12)  R (8)  +    + 
E15 C. jejuni R (> 64) R (> 8) + S (0,5)  R (16)   S (0,25)  S (1)  + + + 
E16 C. coli R (16) R (> 8) + R (> 16) + R (4)   S (0,12)  R (> 64)  + + + 
Total 100% 100% 81% 75% 13% 56%
Efflux 
pump 
CmeA,B,C
Isolates Species
Quinolones Tetracycline Aminoglycosides Macrolide
TABLE 2. DISTRIBUTION OF VIRULENCE GENES IN C. JEJUNI AND C. COLI ISOLATES* 
Isolates Species 
  Motilitya   GBS   
Hippuricase 
gene 
  
Multidrug and bile 
resistance 
  
Iron 
uptake 
  flaA flaB    wlaN   hipO   cmeA cmeB cmeC   cfrA fur 
A1 C. coli 
 
+	 +	
 
		
 
		
 +	 +	 +	  +	 +	
A2 C. jejuni 
 
		 +	
 
		
 +	  +	 +	 +	  +	 +	
B3 C. jejuni 
 
+	 +	
 
		
 +	  +	 +	 +	  +	 +	
B4 C. jejuni 
 
+	 +	
 
		
 +	  +	 +	 +	  +	 +	
B5 C. jejuni 
 
+	 +	
 
		
 +	  +	 +	 +	  +	 +	
B6 C. jejuni 
 
		 +	
 
		
 +	  +	 +	 +	  +	 +	
C7 C. coli 
 
+	 +	
 
		
 
		
 +	 +	 +	  +	 +	
C8 C. coli 
 
+	 +	
 
		
 
		
 +	 +	 +	  +	 +	
C9 C. jejuni 
 
+	 +	
 +	  +	  +	 +	 +	  +	 +	
C10 C. jejuni 
 
		 +	
 
		
 +	  +	 +	 +	  +	 +	
D11 C. jejuni 
 
+	 +	
 
		
 +	  +	 +	 +	  +	 +	
D12 C. jejuni 
 
		 +	
 
		
 +	  +	 +	 +	  +	 +	
E13 C. jejuni 
 
+	 +	
 +	  +	  +	 +	 +	  +	 +	
E14 C. jejuni 
 
		 +	
 
		
 +	  +	
		 +	  +	 +	
E15 C. jejuni 
 
+	 +	
 
		
 +	  +	 +	 +	  
		 +	
E16 C. coli 
 
+	 +	
 
		
 
		
 +	 +	 +	  +	 +	
Total     11	 16	   2	   12	   16	 15	 16	   15	 16	
 
*The presence of  genes related to  motility (flhA, flhB, flgB, flgE, fliM, fliY); chemotaxis (cheA, cheB, cheR, cheW, cheY);  adhesion (cadF, dnaJ, pdlA, racR); 
capsule (kpsM, waaF); Invasion (iamA, ciaB, ceuE); Cytolethal distending toxin (cdta, cdtB, cdtC); Stress response and survival (katA, sodB), was also 
confirmed in all the isolates, (data not shown to facilitate the reading). aThe results for fla genes was confirmed by PCR. 
SUPPLEMENTARY TABLE 1. ASSEMBLY METRICS 
Isolates Species   N50   
Assembly 
size 
  
Nº 
contigs 
  Coverage 
A1 C. coli 
 
52.853 1.746.294 133 49.73 
A2 C. jejuni 
 
102.764 1.713.572 45 114.7 
B3 C. jejuni 
 
59.250 1.730.328 100 85.37 
B4 C. jejuni 
 
106.203 1.748.765 34 72.99 
B5 C. jejuni 
 
66.683 1.688.181 130 82.47 
B6 C. jejuni 
 
221.977 1.688.205 36 100.3 
C7 C. coli 
 
168.863 1.638.379 62 75.94 
C8 C. coli 
 
166.289 1.746.251 58 127.2 
C9 C. jejuni 
 
91.129 1.723.771 55 89.97 
C10 C. jejuni 
 
162.254 1.690.078 30 120.6 
D11 C. jejuni 
 
148.283 1.675.334 53 86.66 
D12 C. jejuni 
 
91.211 1.705.710 68 117.6 
E13 C. jejuni 
 
79.604 1.677.193 72 104.4 
E14 C. jejuni 
 
83.132 1.811.001 97 78.98 
E15 C. jejuni 
 
59.658 1.591.333 93 65.64 
E16 C. coli 
 
79.519 1.687.906 49 100.6 
                    
 
SUPPLEMENTARY TABLE 2. VIRULENCE ASSOCIATED GENES 
CONSIDERED IN THIS STUDY AND THEIR CORRESPONDING LOCUS TAG 
Genes 
Locus tag 
C. jejuni C. coli 
flaA Cj0887c VC76_04395 
flaB Cj0887c VC76_03535 
flhA Cj0882c VC76_04415 
flhB Cj0335 VC76_01775 
flgB Cj0526c VC76_02755 
flgE Cj1729c VC76_08610 
fliM Cj0060c VC76_00300 
fliY Cj0059c VC76_03960 
cheA Cj0284c VC76_01475 
cheB Cj0924c VC76_04655 
cheR Cj0923c VC76_04650 
cheW Cj0283c VC76_01470 
cheY Cj1118c VC76_05495 
cadF Cj1478c VC76_07295 
dnaJ Cj0954c VC76_03025 
pldA Cj1351 VC76_06765 
racR Cj1261 VC76_03020" 
cdtA Cj0079c VC76_01515 
cdtB Cj0078c VC76_01510 
cdtC Cj0077c VC76_01505 
wlaN Cj1139c Absent 
iamA Cj1647 VC76_00545 
ciaB Cj0914c VC76_04610 
ceuE Cj1355 VC76_06790 
cmeA Cj0365c VC76_01930 
cmeB Cj0366c VC76_01925 
cmeC Cj0365c VC76_07315 
katA Cj1385 VC76_06950 
sodB Cj0169 VC76_07880 
cfrA Cj0755 VC76_03645 
fur Cj0400 VC76_02095 
kpsM Cj1448c VC76_07145 
waaF Cj1148 VC76_05560 
hipO Cj0985c Absent 
      
 
SUPPLEMENTARY TABLE 3. HOMOLOGY ANALYSES OF EACH STUDIED GENE OF THE REFERENCE STRAINS (C. jejuni NCTC 
11168 and C. coli FB1) WITH RESPECT TO THE CORRESPONDING GENES IN THE TESTED ISOLATES 
Isolates Species 
  Motility 
  flaA   flaB   flhA   flhB 
  % Identity Query/HSP length   % Identity Query/HSP length   % Identity Query/HSP length   % Identity Query/HSP length 
A1 C. coli   95.12 2253/2253   99.47 756/756   99.91 2178/2178   100 1089/1089 
A2 C. jejuni        
    
 100 2175/2175   100 1089/1089 
B3 C. jejuni        
    
 99.72 2175/2175   99.82 1089/1089 
B4 C. jejuni   98.59 1133/1719 98.15 1133/1719 99.95 2175/2175   100 1089/1089 
B5 C. jejuni   97.07 1261/1719      100 2175/2175   98.16 1086/1089 
B6 C. jejuni        
    
 99.72 2175/2175   99.82 1089/1089 
C7 C. coli   97.96 2253/2253 100 756/756 100 2178/2178   100 1089/1089 
C8 C. coli   95.12 2253/2253 99.47 756/756 99.91 2178/2179   100 1089/1089 
C9 C. jejuni   99.38 1133/1719 99.82 1113/1719 100 2175/2175   99.91 1089/1089 
C10 C. jejuni        
    
 99.72 2175/2175   99.82 1089/1089 
D11 C. jejuni   92.64 1263/1719      99.95 2175/2175   100 1089/1089 
D12 C. jejuni        
    
 99.95 2175/2175   100 1089/1089 
E13 C. jejuni   98.73 1261/1719      98.73 1261/1719   99.91 1089/1089 
E14 C. jejuni        
    
 99.91 2175/2175   99.72 1089/1089 
E15 C. jejuni   91.77 1325/1719      91.77 1325/1719   99.82 1089/1089 
E16 C. coli   96.40 2253/2253   100 756/756   100 2178/2178   100 1089/1089 
                            
 
  
SUPPLEMENTARY TABLE 3 CONTINUED. 
Isolates Species 
  Motility 
  flgB   flgE   fliM   fliY 
  % Identity Query/HSP length   % Identity Query/HSP length   % Identity Query/HSP length   % Identity Query/HSP length 
A1 C. coli   100 432/432   95.91 1638/1638   92.04 1080/1080   99.74 771/771 
A2 C. jejuni   97.22 432/432   99.82 1638/1638   99.63 1080/1080   99.64 843/843 
B3 C. jejuni   96.76 432/432   99.88 1638/1638   100 1080/1080   100 843/843 
B4 C. jejuni   100 432/432   99.82 1638/1638   98.43 1080/1080   99.76 843/843 
B5 C. jejuni   100 432/432   100 1638/1638   98.43 1080/1080   99.76 843/843 
B6 C. jejuni   96.76 432/432   98.78 1638/1638   92.41 1080/1080   100 843/843 
C7 C. coli   100 432/432   98.78 1638/1638   92.41 1080/1080   99.87 771/771 
C8 C. coli   100 432/432   95.91 1638/1638   90.37 1080/1080   99.74 771/771 
C9 C. jejuni   100 432/432   100 1638/1638   98.43 1080/1080   99.76 843/843 
C10 C. jejuni   96.76 432/432   99.88 1638/1638   100 1080/1080   100 843/843 
D11 C. jejuni   97.22 432/432   99.88 1638/1638   98.43 1080/1080   99.64 843/843 
D12 C. jejuni   100 432/432   99.82 1638/1638   98.43 1080/1080   99.76 843/843 
E13 C. jejuni   97.22 432/432   99.88 1638/1638   98.43 1080/1080   99.64 843/843 
E14 C. jejuni   97.22 432/432   99.88 1638/1638   98.06 1080/1080   99.53 843/843 
E15 C. jejuni   99.77 432/432   99.88 1638/1638   97.69 1080/1080   99.56 843/843 
E16 C. coli   100 432/432   98.41 1638/1638   92.41 1080/1080   99.74 771/771 
                            
 
SUPPLEMENTARY TABLE 3 CONTINUED. 
Isolates Species 
  Chemotaxis 
  cheA   cheB   cheR   cheW   cheY 
  % Identity Query/HSP length   % Identity Query/HSP length   % Identity Query/HSP length   % Identity Query/HSP length   % Identity Query/HSP length 
A1 C. coli   99.96 2295/2295   100 555/555   99.87 798/798   100 522/522   100 957/957 
A2 C. jejuni   99.96 2310/2310   99.82 555/555   100 798/798   100 522/522   99.75 393/393 
B3 C. jejuni   99.31 2310/2310   99.82 554/555   99.75 798/798   99.81 522/522   99.75 393/393 
B4 C. jejuni   99.48 2310/2310   100 555/555   100 798/798   100 522/522   99.75 393/393 
B5 C. jejuni   99.96 2310/2310   100 555/555   100 798/798   100 522/522   100 393/393 
B6 C. jejuni   99.31 2310/2310   99.82 554/555   99.75 798/798   99.81 522/522   99.75 393/393 
C7 C. coli   100 2295/2295   100 555/555   99.75 798/798   100 522/522   100 957/957 
C8 C. coli   99.96 2295/2295   100 555/555   99.87 798/798   100 522/522   100 957/957 
C9 C. jejuni   99.96 2310/2310   100 555/555   100 798/798   100 522/522   100 393/393 
C10 C. jejuni   99.31 2310/2310   99.82 554/555   99.75 798/798   99.81 522/522   99.75 393/393 
D11 C. jejuni   99.96 2310/2310   100 555/555   100 798/798   100 522/522   99.75 393/393 
D12 C. jejuni   99.48 2310/2310   100 555/555   100 798/798   100 522/522   99.75 393/393 
E13 C. jejuni   99.96 2310/2310   100 555/555   100 798/798   100 522/522   99.75 393/393 
E14 C. jejuni   99.96 2310/2310   100 555/555   99.87 798/798   100 522/522   99.75 393/393 
E15 C. jejuni   98.01 2310/2310   98.74 554/555   99.11 798/798   99.23 522/522   99.49 393/393 
E16 C. coli   100 2295/2295   100 555/555   99.62 798/798   100 522/522   100 957/957 
                                  
 
  
SUPPLEMENTARY TABLE 3 CONTINUED. 
 
Isolates Species 
  Adhesion  
  cadF   dnaJ   pldA   racR 
  % Identity Query/HSP length   % Identity Query/HSP length   % Identity Query/HSP length   % Identity Query/HSP length 
A1 C. coli   99.60 999/999   98.22 1125/1125   100 996/996   99.85 672/672 
A2 C. jejuni   100 960/960   100 1122/1122   99.98 990/990   100 672/672 
B3 C. jejuni   100 960/960   99.73 1122/1122   98.79 990/990   100 672/672 
B4 C. jejuni   100 960/960   99.29 1122/1122   98.69 990/990   99.85 668/672 
B5 C. jejuni   100 960/960   100 1122/1122   100 990/990   100 672/672 
B6 C. jejuni   100 960/960   99.73 1122/1122   98.79 990/990   100 672/672 
C7 C. coli   99.70 999/999   99.73 1125/1125   99.60 996/996   100 672/672 
C8 C. coli   99.60 999/999   98.67 1125/1125   100 996/996   99.85 668/672 
C9 C. jejuni   100 960/960   98.04 1125/1125   100 990/990   99.55 672/672 
C10 C. jejuni   100 960/960   99.73 1122/1122   98.79 990/990   100 672/672 
D11 C. jejuni   100 960/960   100 1122/1122   100 990/990   100 672/672 
D12 C. jejuni   100 960/960   99.29 1122/1122   98.69 990/990   99.85 672/672 
E13 C. jejuni   100 960/960   100 1122/1122   99.90 990/990   100 672/672 
E14 C. jejuni   99.58 960/960   98.76 1122/1122   99.09 990/990   99.70 672/672 
E15 C. jejuni   99.06 960/960   100 1122/1122   98.59 990/990   100 672/672 
E16 C. coli   99.70 999/999   99.20 1125/1125   99.20 996/996   100 672/672 
                            
 
  



